Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation.

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW

Open source

DOI
10.1016/j.arr.2025.102755
Published
2025 Jun
Container
Ageing research reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.arr.2025.102755,
  title = {Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation.},
  author = {Liu Y and Aquili L and Wong KH and Lu Z and Lim LW},
  year = {2025},
  journal = {Ageing research reviews},
  doi = {10.1016/j.arr.2025.102755},
  url = {https://doi.org/10.1016/j.arr.2025.102755}
}

RIS

TY  - JOUR
TI  - Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation.
AU  - Liu Y
AU  - Aquili L
AU  - Wong KH
AU  - Lu Z
AU  - Lim LW
PY  - 2025
JO  - Ageing research reviews
DO  - 10.1016/j.arr.2025.102755
UR  - https://doi.org/10.1016/j.arr.2025.102755
ER  - 

APA

Y, L., L, A., KH, W., Z, L., & LW, L. (2025). Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation.. Ageing research reviews. https://doi.org/10.1016/j.arr.2025.102755

Source records